Dr. Peter Marks, the former director of the FDA’s Center for Biologics Evaluation and Research, urged public health leaders ...

Trump celebrated when the Supreme Court limited nationwide blocks on his policies, but judges are finding other ways to hinder his priorities.

Sarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the FDA.

Ninety-three percent of hospitals responding to a recent survey conducted by 340B Health said they would struggle to maintain current levels of uncompensated care in the wake of drugmakers’ proposed ...

Sarepta Therapeutics’ stock has dropped precipitously as questions swirl around the safety of its gene therapies. Meanwhile, the Duchenne patient community fears losing access to Elevidys while the ...

Markets only work when transparent prices reflect consumers' desires and the producers' costs. While there are complications, ...

McDonald's on Central London's Victoria Street has applied for a 24-hour licence but objectors fear it could lead to more ...

The Good Food Collective, a new coalition of 25-plus food brands, organizations, and nutrition experts, has teamed up to ...

AstraZeneca unveils a $50 billion U.S. manufacturing expansion plan, anchored by a Virginia facility to boost drug output and ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Speaker Mike Johnson said he would shut the House down early for the summer on Wednesday to head off Democrats’ calls for ...

UnitedHealth Group is currently undervalued due to an overblown market reaction to profitability challenges. Click here to ...